These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38203288)

  • 1.
    Bochicchio MT; Marconi G; Baldazzi C; Bandini L; Ruggieri F; Lucchesi A; Agostinelli C; Sabattini E; Orsatti A; Ferrari A; Capirossi G; Servili C; Ghelli Luserna di Rorà A; Martinelli G; Simonetti G; Rosti G
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203288
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors.
    Xie W; Wang SA; Hu S; Xu J; Medeiros LJ; Tang G
    Cancer Genet; 2018 Dec; 228-229():41-46. PubMed ID: 30553471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate.
    Chen F
    Ann Hematol; 2024 Sep; 103(9):3801-3804. PubMed ID: 38992279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
    Uemura S; Nishimura N; Hasegawa D; Shono A; Sakaguchi K; Matsumoto H; Nakamachi Y; Saegusa J; Yokoi T; Tahara T; Tamura A; Yamamoto N; Saito A; Kozaki A; Kishimoto K; Ishida T; Nino N; Takafuji S; Mori T; Iijima K; Kosaka Y
    Int J Hematol; 2018 May; 107(5):604-609. PubMed ID: 29177615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloproliferative Neoplasm Driven by
    Renzi S; Algawahmed F; Davidson S; Langenberg KPS; Fuligni F; Ali S; Anderson N; Brunga L; Bartram J; Abdelhaleem M; Naqvi A; Beimnet K; Schuh A; Tierens A; Malkin D; Shlien A; Shago M; Villani A
    Curr Oncol; 2023 Jun; 30(7):5946-5952. PubMed ID: 37503586
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
    Barbouti A; Ahlgren T; Johansson B; Höglund M; Lassen C; Turesson I; Mitelman F; Fioretos T
    Br J Haematol; 2003 Jul; 122(1):85-93. PubMed ID: 12823349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
    La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
    Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.
    Gancheva K; Virchis A; Howard-Reeves J; Cross NC; Brazma D; Grace C; Kotzampaltiris P; Partheniou F; Nacheva E
    Mol Cytogenet; 2013 Sep; 6(1):39. PubMed ID: 24053143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Zimmermannova O; Doktorova E; Stuchly J; Kanderova V; Kuzilkova D; Strnad H; Starkova J; Alberich-Jorda M; Falkenburg JHF; Trka J; Petrak J; Zuna J; Zaliova M
    Oncogene; 2017 Oct; 36(43):5985-5994. PubMed ID: 28650474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-phenotype (B-lymphocytic/myeloid) acute leukemia with ETV6-ABL1 expression.
    Wang L; He D; Lu L; Wang H; Wang S
    Pak J Med Sci; 2024 Jul; 40(6):1294-1299. PubMed ID: 38952502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
    Schwaab J; Naumann N; Luebke J; Jawhar M; Somervaille TCP; Williams MS; Frewin R; Jost PJ; Lichtenegger FS; La Rosée P; Storch N; Haferlach T; Horny HP; Fabarius A; Haferlach C; Burchert A; Hofmann WK; Cross NCP; Hochhaus A; Reiter A; Metzgeroth G
    Am J Hematol; 2020 Jul; 95(7):824-833. PubMed ID: 32279331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia.
    Xue S; Sun HP; Huang XB; Chen X; Wang T; Ma W; Tian Y; Pan ZL; Li LH; Zhang L; Liu HX; Cao XY
    Int J Hematol; 2024 May; 119(5):564-572. PubMed ID: 38441775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.
    Tirado CA; Siangchin K; Shabsovich DS; Sharifian M; Schiller G
    Biomark Res; 2016; 4(1):16. PubMed ID: 27570624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
    La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
    Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic
    Stukaite-Ruibiene E; Norvilas R; Dirse V; Stankeviciene S; Vaitkeviciene GE
    Pathol Oncol Res; 2022; 28():1610570. PubMed ID: 36172171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.
    Ma ESK; Wan TSK; Au CH; Ho DN; Ma SY; Ng MHL; Chan TL
    Cancer Genet; 2017 Dec; 218-219():15-19. PubMed ID: 29153093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.
    Kakadia PM; Schmidmaier R; Völkl A; Schneider I; Huk N; Schneider S; Panzner G; Neidel U; Fritz B; Spiekermann K; Bohlander SK
    Leuk Res Rep; 2016; 6():50-54. PubMed ID: 27812500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant of ETV6/ABL1 gene is associated with leukemia phenotype.
    Park J; Kim M; Lim J; Kim Y; Han K; Kim JS; Lee S; Kim HJ; Min WS
    Acta Haematol; 2013; 129(2):78-82. PubMed ID: 23171811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
    Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
    N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.